Skip to main content
. 2022 May 28;10(6):292. doi: 10.3390/toxics10060292

Table 4.

Adjusted a trimester-specific associations of urinary phthalate and phthalate replacement metabolite concentrations with serum levels of lipid biomarkers among 175 pregnant women in the Environment and Reproductive Health (EARTH) Study.

Trimester 1
Median 8 Weeks
(N = 61)
Trimester 2
Median 23 Weeks
(N = 47)
Trimester 3
Median 34 Weeks
(N = 67)
MBP Triglycerides, mg/dL
Q1 88.7 (61.5, 116) 159 (121, 1970) 262 (221, 304)
Q2 120 (91.2, 148) 183 (158, 209) 323 (288, 358)
Q3 116 (93.6, 139) 182 (154, 209) 231 (185, 277)
Q4 116 (96.5, 136) 208 (182, 235) ‡ 306 (250, 360)
Non-HDL cholesterol, mg/dL
Q1 101 (87.8, 114) 132 (104, 161) 216 (188, 244)
Q2 113 (98.8, 127) 171 (152, 190) * 211 (187, 235)
Q3 120 (108, 131) * 173 (152, 194) * 190 (159, 222)
Q4 117 (107, 127) ǂ 196 (176, 217) * 244 (207, 282)
MEHP Total cholesterol, mg/dL
G1 184 (170, 199) 221 (198, 244) 271 (249, 293)
G2 192 (173, 209) 228 (202, 255) 288 (261, 314)
G3 168 (152, 183) 246 (229, 264) * 271 (233, 311)
G4 173 (162, 184) 277 (259, 296) * 325 (286, 364)*
Non-HDL cholesterol, mg/dL
G1 121 (109, 134) 144 (120, 167) 201 (179, 223)
G2 118 (103, 134) 159 (132, 1860 214 (188, 240)
G3 103 (89.5, 116) ǂ 171 (153, 188) * 198 (160, 237)
G4 111 (102, 121) 197 (179, 217) * 262 (224, 300) *
LDL cholesterol, mg/dL
G1 103 (91.1, 114) 112 (92.2, 132) 145 (125, 166)
G2 100 (85.9, 114) 124 (101, 146) 157 (132, 181)
G3 78.5 (66.5, 90.5) * 131 (116, 146) 154 (118, 190)
G4 87.1 (78.3, 95.9) ǂ 160 (144, 176) * 196 (161, 233)
MEOHP Total cholesterol, mg/dL
Q1 181 (166, 197) 213 (189, 237) 286 (258, 316)
Q2 179 (165, 193) 244 (220, 268) ‡ 270 (245, 2940
Q3 168 (153, 182) 242 (224, 261) ‡ 276 (248, 303)
Q4 178 (166, 191) 287 (265, 309) * 320 (281, 359)
Non-HDL cholesterol, mg/dL
Q1 115 (102, 128) 139 (116, 163) 218 (189, 247)
Q2 109 (97.2, 121) 167 (143, 191) ‡ 196 (172, 221)
Q3 108 (95.5, 119) 165 (147, 184) ‡ 207 (180, 235)
Q4 118 (108, 129) 210 (189, 231) * 248 (209, 287)
LDL cholesterol, mg/dL
Q1 100 (87.9, 112) 104 (84.1, 124) 164 (138, 190)
Q2 91.6 (80.5, 103) 132 (112, 153) * 139 (116, 161)
Q3 80.8 (69.7, 91.9) * 129 (113, 145) ǂ 151 (126, 176)
Q4 91.7 (82.1, 101) 170 (151, 188) * 192 (157, 228)
MECPP Total cholesterol, mg/dL
Q1 177 (163, 191) 213 (186, 240) 272 (240, 305)
Q2 185 (171, 200) 237 (213, 261) 285 (261, 308)
Q3 174 (160, 188) 240 (220, 260) 272 (244, 299)
Q4 175 (162, 187) 286 (263, 308) * 323 (284, 363)
Non-HDL cholesterol, mg/dL
Q1 112 (99.5, 124) 139 (112, 165) 203 (170, 235)
Q2 116 (104, 128) 163 (140, 186) 211 (187, 235)
Q3 110 (97.5, 122) 158 (140, 177) 204 (176, 232)
Q4 116 (105, 127) 211 (190, 233) * 255 (216, 294) ǂ
LDL cholesterol, mg/dL
Q1 92.4 (81.0, 104) 106 (82.9, 128) 148 (118, 177)
Q2 94.1 (82.3, 106) 126 (106, 146) 157 (135, 179)
Q3 86.6 (75.2, 98.0) 124 (108, 141) 145 (120, 171)
Q4 91.5 (81.2, 102) 170 (151, 188) * 197 (161, 233) ǂ
Non-HDL cholesterol, mg/dL
MHiNCH
G1 non-detectable 103 (92.4, 114) 140 (114, 165) 176 (117, 234)
G2 detectable 114 (106, 121) 160 (146, 174) 199 (183, 215)
Non-HDL cholesterol, mg/dL
MCOCH
G1 non-detectable 109 (93.4, 124) 163 (152, 174) 149 (107, 189)
G2 detectable 110 (104, 116) 195 (134, 256) 196 (182, 211) *

a Data are presented as predicted marginal means (95% CI) unless otherwise noted, adjusted for age at pregnancy, pre-pregnancy BMI, education, infertility diagnosis, cycle type, number of babies, and specific gravity. * p-value < 0.05 when comparing that group with the lowest group. ‡ p-value < 0.10 when comparing that group with the lowest group. Mono-n-butyl phthalate (MBP); mono-isobutyl phthalate (MiBP); monoethyl phthalate (MEP); monobenzyl phthalate (MBzP); mono(2-ethylhexyl) phthalate (MEHP); mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP); mono(2-ethyl-5-oxohexyl) phthalate (MEOHP); mono(2-ethyl-5-carboxypentyl) phthalate (MECPP); cyclohexane-1,2-dicarboxylic acid monohydroxy isononyl ester (MHiNCH); cyclohexane-1,2-dicarboxylic acid monocarboxyisooctyl ester (MCOCH).